AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 153 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 1.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $439,200 | -4.3% | 240,000 | -62.4% | 0.01% | -27.3% |
| Q1 2022 | $459,000 | +1175.0% | 638,600 | +3935.9% | 0.01% | +1000.0% |
| Q4 2021 | $36,000 | -83.4% | 15,823 | -79.0% | 0.00% | -83.3% |
| Q3 2021 | $217,000 | +13.0% | 75,240 | +48.2% | 0.01% | 0.0% |
| Q2 2021 | $192,000 | +65.5% | 50,772 | +48.0% | 0.01% | +50.0% |
| Q1 2021 | $116,000 | +114.8% | 34,302 | +77.4% | 0.00% | +100.0% |
| Q4 2020 | $54,000 | +3.8% | 19,332 | -6.2% | 0.00% | -33.3% |
| Q3 2020 | $52,000 | -81.3% | 20,620 | -71.0% | 0.00% | -88.0% |
| Q3 2019 | $278,000 | -67.4% | 71,000 | -31.7% | 0.02% | -69.9% |
| Q1 2019 | $852,000 | +134.1% | 104,000 | +57.9% | 0.08% | +56.6% |
| Q4 2018 | $364,000 | – | 65,852 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,121,283 | $53,979,000 | 4.02% |
| DAFNA Capital Management LLC | 853,538 | $6,470,000 | 2.70% |
| Baupost Group | 17,527,968 | $132,862,000 | 1.96% |
| Nantahala Capital Management | 6,559,478 | $49,721,000 | 1.86% |
| Novo Holdings A/S | 3,393,039 | $25,719,000 | 1.72% |
| Abrams Capital Management | 5,656,462 | $42,876,000 | 1.69% |
| Stanley-Laman Group, Ltd. | 319,073 | $2,419,000 | 0.73% |
| Integral Health Asset Management, LLC | 200,000 | $1,516,000 | 0.67% |
| KNOTT DAVID M | 135,169 | $1,025,000 | 0.65% |
| Leap Investments LP | 54,700 | $415,000 | 0.61% |